Literature DB >> 23410793

Factors associated with inadequate early vancomycin levels in critically ill patients treated with continuous infusion.

J J De Waele1, I Danneels, P Depuydt, J Decruyenaere, M Bourgeois, E Hoste.   

Abstract

Vancomycin administration using a loading dose and continuous infusion (CI) results in more rapid attainment of adequate concentrations. The aim of this retrospective study of ICU patients receiving vancomycin was to determine the efficacy of a vancomycin dosing protocol using a weight-based loading dose and to identify factors associated with inadequate concentrations. Patients received a loading dose (<65 kg, 1000 mg; ≥65 kg, 1500 mg), and 2000 mg/24 h CI with subsequent dose adaptation. Adequate levels were defined as concentrations ≥15 mg/L. In total, 227 patients (154 males) were included in the study (mean age 56.5 ± 16.1 years; mean APACHE II score 19.30 ± 7.7). The mean loading dose was 1129 ± 369 mg (15.07 ± 4.99 mg/kg). The dosing protocol was applied in 126 patients (55.5%). Mean vancomycin levels were 19.32 mg/L and 21.08 mg/L on Days 2 and 3, respectively. Vancomycin levels on Day 2 were adequate in 70.5% of patients, increasing to 84.1% on Day 3. Patients who received an appropriate loading dose more often had adequate vancomycin levels on Day 2. Older age, female sex, higher creatinine concentration, lower body temperature and use of a loading dose according to the vancomycin dosing protocol were independently associated with adequate vancomycin levels. A weight-based loading dose plus CI of vancomycin resulted in adequate concentrations in most patients and was superior compared with a non-standardised loading dose. Some patients may require higher doses, and factors other than weight, such as kidney function, age and sex, play a role.
Copyright © 2013 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23410793     DOI: 10.1016/j.ijantimicag.2012.12.015

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  12 in total

Review 1.  Clinical implications of antibiotic pharmacokinetic principles in the critically ill.

Authors:  Andrew A Udy; Jason A Roberts; Jeffrey Lipman
Journal:  Intensive Care Med       Date:  2013-09-18       Impact factor: 17.440

2.  Design and prospective validation of a dosing instrument for continuous infusion of vancomycin: a within-population approach.

Authors:  Erik M van Maarseveen; Annemien Bouma; Daniel J Touw; Cees Neef; Arthur R H van Zanten
Journal:  Eur J Clin Pharmacol       Date:  2014-08-30       Impact factor: 2.953

3.  The association of elevated trough serum vancomycin concentrations with obesity.

Authors:  Janice Richardson; Marc Scheetz; E Paul O'Donnell
Journal:  J Infect Chemother       Date:  2015-03-20       Impact factor: 2.211

4.  Optimal vancomycin doses for methicillin-resistant Staphylococcus aureus infection in urological renal dysfunction patients.

Authors:  Katsumi Shigemura; Kayo Osawa; Fukashi Yamamichi; Kazushi Tanaka; Issei Tokimatsu; Soichi Arakawa; Masato Fujisawa
Journal:  Int Urol Nephrol       Date:  2015-04-22       Impact factor: 2.370

Review 5.  Vancomycin dosing nomograms targeting high serum trough levels in different populations: pros and cons.

Authors:  Sepideh Elyasi; Hossein Khalili
Journal:  Eur J Clin Pharmacol       Date:  2016-04-27       Impact factor: 2.953

6.  New Regimen for Continuous Infusion of Vancomycin in Critically Ill Patients.

Authors:  Stefano Cristallini; Maya Hites; Hakim Kabtouri; Jason A Roberts; Marjorie Beumier; Frederic Cotton; Jeffrey Lipman; Frédérique Jacobs; Jean-Louis Vincent; Jacques Creteur; Fabio Silvio Taccone
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

Review 7.  How do we use therapeutic drug monitoring to improve outcomes from severe infections in critically ill patients?

Authors:  Gloria Wong; Fekade Bruck Sime; Jeffrey Lipman; Jason A Roberts
Journal:  BMC Infect Dis       Date:  2014-11-28       Impact factor: 3.090

8.  Decreasing the time to achieve therapeutic vancomycin concentrations in critically ill patients: developing and testing of a dosing nomogram.

Authors:  João Pedro Baptista; Jason A Roberts; Eduardo Sousa; Ricardo Freitas; Nuno Deveza; Jorge Pimentel
Journal:  Crit Care       Date:  2014-12-05       Impact factor: 9.097

9.  Does contemporary vancomycin dosing achieve therapeutic targets in a heterogeneous clinical cohort of critically ill patients? Data from the multinational DALI study.

Authors:  Stijn Blot; Despoina Koulenti; Murat Akova; Matteo Bassetti; Jan J De Waele; George Dimopoulos; Kirsi-Maija Kaukonen; Claude Martin; Philippe Montravers; Jordi Rello; Andrew Rhodes; Therese Starr; Steven C Wallis; Jeffrey Lipman; Jason A Roberts
Journal:  Crit Care       Date:  2014-05-15       Impact factor: 9.097

10.  Trough Concentrations of Vancomycin in Patients Undergoing Extracorporeal Membrane Oxygenation.

Authors:  So Jin Park; Jeong Hoon Yang; Hyo Jung Park; Yong Won In; Young Mi Lee; Yang Hyun Cho; Chi Ryang Chung; Chi-Min Park; Kyeongman Jeon; Gee Young Suh
Journal:  PLoS One       Date:  2015-11-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.